Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
4.120
-0.280 (-6.36%)
At close: Sep 5, 2025, 4:00 PM
4.210
+0.090 (2.18%)
After-hours: Sep 5, 2025, 7:40 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $30.92 million as of September 5, 2025. Its market cap has increased by 249.62% in one year.
Market Cap
30.92M
Enterprise Value
38.40M
1-Year Change
249.62%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $30.92M, a decrease of -70.13%. That is a compound annual growth rate of -22.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 33.02M | 30.69% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
| Dec 11, 2020 | 103.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |